Sandoz welcomes Dutch antitrust probe into Biogen test after raising concerns
By Jean Comte ( October 30, 2026, 14:40 GMT | Insight) -- Swiss pharmaceutical company Sandoz has welcomed a decision this week by the Dutch competition regulator to probe Biogen's possible abuse of dominant position over a product linked to the treatment of multiple sclerosis. Sandoz, which is at the center of a similar Italian investigation, confirmed to MLex that it had "raised concerns" with the Dutch regulator.Swiss pharmaceutical company Sandoz has welcomed a decision this week by the Dutch competition regulator to probe Biogen's possible abuse of dominant position over a product linked to the treatment of multiple sclerosis....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.